Difference between revisions of "Medical Technology Group"
m (Reverted edits by Martin Svalastog (talk) to last revision by Melissa Jones) |
(reverting to original description - correcting inaccuracies/removing press release style bumpf) |
||
| Line 1: | Line 1: | ||
| − | The | + | The Medical Technology Group (MTG) describes itself as "a coalition of patient groups, research charities and medical device manufacturers working to make medical technologies available to everyone who needs them."<ref> MTG website [http://www.mtg.org.uk/go.cfm?do=Page.Show&pid=2 About MTG], accessed Nov 2010</ref> The Group was launched in 2000 to lobby for medical technologies in the NHS. |
| − | |||
| − | The | ||
==Economy== | ==Economy== | ||
| − | + | The UK medical technology sector in 2010 consists of 3034 companies generating a turnover of £13.1bn and employing 55,000 individuals. [[Barbara Harpham]], Medical Technology Group chairman and director of [[Heart Research UK]] claims that, the UK lags behind many other European countries, with problems like hospitals denying patients NICE-approved technologies because they lack the facilities or staff to support their use.<ref> "Nursing Times'' [http://www.nursingtimes.net/whats-new-in-nursing/news-topics/health-informatics/nhs-must-boost-use-of-technology-or-risk-falling-behind/5008942.article NHS "must boost use of technology" or risk falling behind] 25.11.2009, accessed 09.04.2011 </ref> | |
[[Norman Lamb]] MP, the Liberal Democrat Shadow Health Secretary, agrees there should be more focus on medical technology. He says that, “adoption of medical technologies is often both cost effective and in the patient’s interest. Up until now, the NHS has been slow to recognise the value of technology. This has to change if we are to maximise the effective use of resources for the benefit of patients”. <ref> Scottish Healthcare [http://www.scottishhealthcare.com/2009/11/page/2/ Medical Technology Group Warns Against "Slow-Tech" NHS] 25.11.2009, accessed 04.042011</ref> | [[Norman Lamb]] MP, the Liberal Democrat Shadow Health Secretary, agrees there should be more focus on medical technology. He says that, “adoption of medical technologies is often both cost effective and in the patient’s interest. Up until now, the NHS has been slow to recognise the value of technology. This has to change if we are to maximise the effective use of resources for the benefit of patients”. <ref> Scottish Healthcare [http://www.scottishhealthcare.com/2009/11/page/2/ Medical Technology Group Warns Against "Slow-Tech" NHS] 25.11.2009, accessed 04.042011</ref> | ||
| Line 13: | Line 11: | ||
==Medical Technology== | ==Medical Technology== | ||
AdvaMed claims that medical technology is used to diagnose, monitor or treat every disease or condition that affects humans. They write that these innovative technologies are improving the quality of health care delivered and patient outcomes through earlier diagnosis, less invasive treatment options and reductions in hospital stays and rehabilitation times. <ref> AdvaMed [http://www.advamed.org/MemberPortal/About/NewsRoom/MediaKits/whatismedtechnology.htm What is Medical Technology?], 14.09.2004, accessed 06.04.2011 </ref> Barbara Harpham says that, “slashing budgets is counterproductive as modern technologies help thousands of people stay in work and out of hospital” <ref> Scottish Healthcare [http://www.scottishhealthcare.com/2009/11/page/2/ NHS 'must boost use of technology], 25.11.2009, accessed 09.04.2011 </ref> The global medical publisher, [[BMJ Group]] writes that, “medical technologies can improve clinical outcomes and experiences of patients and support the wellbeing and personal development of individuals. They can help to achieve savings for the NHS and other areas of public spending in a tight budgetary climate, by improving rehabilitation and independence, supporting care closer to home, and reducing planned and emergency hospital admissions”. <ref> BMJ Group [http://www.bmj.com/content/342/bmj.d566.short/reply UK must increase uptake of medical technology to close gap with Europe] 03.02.2011, accessed 03.04.2011 </ref> | AdvaMed claims that medical technology is used to diagnose, monitor or treat every disease or condition that affects humans. They write that these innovative technologies are improving the quality of health care delivered and patient outcomes through earlier diagnosis, less invasive treatment options and reductions in hospital stays and rehabilitation times. <ref> AdvaMed [http://www.advamed.org/MemberPortal/About/NewsRoom/MediaKits/whatismedtechnology.htm What is Medical Technology?], 14.09.2004, accessed 06.04.2011 </ref> Barbara Harpham says that, “slashing budgets is counterproductive as modern technologies help thousands of people stay in work and out of hospital” <ref> Scottish Healthcare [http://www.scottishhealthcare.com/2009/11/page/2/ NHS 'must boost use of technology], 25.11.2009, accessed 09.04.2011 </ref> The global medical publisher, [[BMJ Group]] writes that, “medical technologies can improve clinical outcomes and experiences of patients and support the wellbeing and personal development of individuals. They can help to achieve savings for the NHS and other areas of public spending in a tight budgetary climate, by improving rehabilitation and independence, supporting care closer to home, and reducing planned and emergency hospital admissions”. <ref> BMJ Group [http://www.bmj.com/content/342/bmj.d566.short/reply UK must increase uptake of medical technology to close gap with Europe] 03.02.2011, accessed 03.04.2011 </ref> | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
==MTG members== | ==MTG members== | ||
| Line 27: | Line 18: | ||
==Lobbying and Other Benefits of Membership== | ==Lobbying and Other Benefits of Membership== | ||
| + | |||
===Weber Shandwick=== | ===Weber Shandwick=== | ||
| Line 60: | Line 52: | ||
===2008=== | ===2008=== | ||
| − | + | Attended the 2008 Party Conferences, to 'raise awareness of the under-adoption of medical technology'. Offered MPs the chance to check they had healthy hearts. MTG takes patients’ views to a wider group of MPs and Peers at our annual Parliamentary Showcase. MTG appeared regularly in the media, in 2008, to help policy makers and the public learn about the benefits of medical technology. They also think they started to shape the policy agenda. In 2008 MTG worked with parliamentarians to table an amendment to the Health and Social Care Bill. They means that this encouraged the Care Quality Commission to take into account medical technology’s ability to generate cost savings across Government. MTG had regular meetings with NICE, and the meetings helped to ensure that insulin pumps were the very first technology to be the subject of a Commissioning Guide. This supported the NHS in providing more patients with diabetes with this “life-changing technology”. MTG also believes that their submissions to NICE help to convey patients’ views to this key public body, while their briefings to Parliamentarians on current legislation like the Health Bill explain to MPs and Peers the views of their members. <ref> MTG [http://www.mtg.org.uk/go.cfm?do=Page.Show&pid=14 MTG successes], accessed 20.02.2011 </ref> | |
===2009=== | ===2009=== | ||
| − | MTG ran a number of campaigns throughout 2009, | + | MTG ran a number of campaigns throughout 2009, including: publication of MTG Action Plan, research into the wider societal benefits of medical technology, Parliamentary Showcase, and dedicated campaign activity. |
| − | Publication of MTG Action Plan: The report “Medical Technology – Can we afford to miss out?” highlighted how the UK lags behind many other European countries in its uptake of proven effective technologies. The report gained broad media coverage, including | + | Publication of MTG Action Plan: The report “Medical Technology – Can we afford to miss out?” highlighted how the UK lags behind many other European countries in its uptake of proven effective technologies. The report gained broad media coverage, including from the BBC, HSJ and Pharma Times amongst others. The Action Plan has also been endorsed by front bench MPs from both the Conservative and Liberal Democrats.
|
| − | |||
Research into the wider societal benefits of medical technology: MTG commissioned the York Health Economics Consortium to produce a report which would demonstrate the wider societal benefits of medical technologies, the first phase of this was completed in August. | Research into the wider societal benefits of medical technology: MTG commissioned the York Health Economics Consortium to produce a report which would demonstrate the wider societal benefits of medical technologies, the first phase of this was completed in August. | ||
| − | |||
Parliamentary Showcase: The annual Parliamentary Showcase was held on 13 October at Portcullis House. 18 parliamentarians attended over the course of the event including Norman Lamb MP and Sandra Gidley MP from the Shadow Lib Dem health team, high profile labour MPs, the Deputy Speaker of the House of Commons Sir Alan Haselhurst, and a number of Conservative and cross-bench peers with an interest in health.
| Parliamentary Showcase: The annual Parliamentary Showcase was held on 13 October at Portcullis House. 18 parliamentarians attended over the course of the event including Norman Lamb MP and Sandra Gidley MP from the Shadow Lib Dem health team, high profile labour MPs, the Deputy Speaker of the House of Commons Sir Alan Haselhurst, and a number of Conservative and cross-bench peers with an interest in health.
| ||
| − | |||
Dedicated campaign activity: MTG ran a number of dedicated campaigns, the first of these was around increasing the uptake of Insulin Pumps. MTG had liaised with a number of MPs and expect a series of outputs throughout 2010 <ref> ABHI [http://www.abhi.org.uk/key-issues/public-affairs/medical-technology-group.aspx Medical Technology Group], accessed 14.02.2011 </ref> | Dedicated campaign activity: MTG ran a number of dedicated campaigns, the first of these was around increasing the uptake of Insulin Pumps. MTG had liaised with a number of MPs and expect a series of outputs throughout 2010 <ref> ABHI [http://www.abhi.org.uk/key-issues/public-affairs/medical-technology-group.aspx Medical Technology Group], accessed 14.02.2011 </ref> | ||
| − | |||
If you would like to view full summary of MTG’s achievements in 2009 follow this link: http://www.abhi.org.uk/multimedia/docs/briefings-in-public/Weber%20Shandwick%20presentation%20FINAL.pdf | If you would like to view full summary of MTG’s achievements in 2009 follow this link: http://www.abhi.org.uk/multimedia/docs/briefings-in-public/Weber%20Shandwick%20presentation%20FINAL.pdf | ||
Revision as of 12:22, 26 September 2011
The Medical Technology Group (MTG) describes itself as "a coalition of patient groups, research charities and medical device manufacturers working to make medical technologies available to everyone who needs them."[1] The Group was launched in 2000 to lobby for medical technologies in the NHS.
Contents
Economy
The UK medical technology sector in 2010 consists of 3034 companies generating a turnover of £13.1bn and employing 55,000 individuals. Barbara Harpham, Medical Technology Group chairman and director of Heart Research UK claims that, the UK lags behind many other European countries, with problems like hospitals denying patients NICE-approved technologies because they lack the facilities or staff to support their use.[2]
Norman Lamb MP, the Liberal Democrat Shadow Health Secretary, agrees there should be more focus on medical technology. He says that, “adoption of medical technologies is often both cost effective and in the patient’s interest. Up until now, the NHS has been slow to recognise the value of technology. This has to change if we are to maximise the effective use of resources for the benefit of patients”. [3]
“The global medical technology market is estimated to be worth £150-170bn and the proportion of healthcare expenditure spent on medical technology is increasing. The USA is the largest market worth over £70bn and has a strong supply base with the majority of world’s largest medical technology companies originating in the country”. [4] “The UK spends just 4.5% of its healthcare budget on technology, compared with a European average of 6.3%. This leads to British patients missing out, for example life saving pacemakers are implanted in Germany at twice the UK rate”. [5]
Medical Technology
AdvaMed claims that medical technology is used to diagnose, monitor or treat every disease or condition that affects humans. They write that these innovative technologies are improving the quality of health care delivered and patient outcomes through earlier diagnosis, less invasive treatment options and reductions in hospital stays and rehabilitation times. [6] Barbara Harpham says that, “slashing budgets is counterproductive as modern technologies help thousands of people stay in work and out of hospital” [7] The global medical publisher, BMJ Group writes that, “medical technologies can improve clinical outcomes and experiences of patients and support the wellbeing and personal development of individuals. They can help to achieve savings for the NHS and other areas of public spending in a tight budgetary climate, by improving rehabilitation and independence, supporting care closer to home, and reducing planned and emergency hospital admissions”. [8]
MTG members
MTG consists of 40 members, and works as a partnership. It includes individual medical technology companies as well as trade associations.
AdvaMed, Abbot Medical Optics, AntiCoagulation Europe, ARMA, Arrhythmia Alliance, Arthritis Care, Atrial Fibrillation Association, Association of British Healthcare Industries, BD, Bladder and Bowel Foundation, Boston Scientific, British Cardiac Patients’ Association, Cardiomyopathy Association, Circulation Foundation, ConvaTec, CR Bard, Dexcom, Eucomed, FABLE, FEmISA, Heart Research UK, ICD Group, Inappropriate Sinus Tachycardia Info and Support, International Alliance of Patients’ Organizations, INPUT, Johnson & Johnson, The Juvenile Diabetes Research Foundation, The Lindsay Leg Club Foundation, Medtronic, National Rheumatoid Arthritis Society, The Patients Association, Patient Information Forum, Pelvic Pain Support Network, Roche Diagnostics, SADS UK, St Jude Medical, STARS, Stryker, Transplant Support Network, Zimmer.[9]
Lobbying and Other Benefits of Membership
Weber Shandwick
PR and lobbying company, Weber Shandwick provides the Secretariat to MTG and acts as its contact point. [10] Shandwick is the UK subsidiary of one of the biggest global PR companies, Weber Shandwick Worldwide, owned by Interpublic. [11]
Membership benefits
MTG sends out a weekly report to members with all relevant media coverage, parliamentary activity and government announcements. It includes information about MTG and Weber Shandwick activity “to keep all members in the loop”. [12]
Membership also includes:
- 'Access to professional public affairs advice on matters relating to the Group'
- 'Training workshops on lobbying effectiveness, media training and other topics'
- 'Opportunities to meet and network with MPs, patient and professional groups and regulatory bodies such as NICE and NHS PASA. [13]
MTG member organizations can be profiled on a variety of events, such as:
- The Labour, Conservative and Liberal Democrat annual conferences
- 'The Medical Technology Showcase in the Houses of Parliament where your technologies could be exhibited to MPs and Lords'
- Articles in MTG’s full-colour ‘Bulletin’ which reaches 1000 senior health decision-makers in parliament and the NHS”. [14]
Contacts
MTG secretariat email: mail@mtg.org.uk [15]
Management Committee
- Chair – Barbara Harpham, Heart Research UK
- Vice-Chair – Richard Phillips, Medtronic
- Treasurer – Sandra Lawrence, Stryker
- John Davis, INPUT
- Joe Gatewood, AdvaMed
- Nathalie Verin, Boston Scientific
- Kieran Murphy, Johnson & Johnson
- Joanna Fearnley, Arrhythmia Alliance [16]
MTG has achieved
2008
Attended the 2008 Party Conferences, to 'raise awareness of the under-adoption of medical technology'. Offered MPs the chance to check they had healthy hearts. MTG takes patients’ views to a wider group of MPs and Peers at our annual Parliamentary Showcase. MTG appeared regularly in the media, in 2008, to help policy makers and the public learn about the benefits of medical technology. They also think they started to shape the policy agenda. In 2008 MTG worked with parliamentarians to table an amendment to the Health and Social Care Bill. They means that this encouraged the Care Quality Commission to take into account medical technology’s ability to generate cost savings across Government. MTG had regular meetings with NICE, and the meetings helped to ensure that insulin pumps were the very first technology to be the subject of a Commissioning Guide. This supported the NHS in providing more patients with diabetes with this “life-changing technology”. MTG also believes that their submissions to NICE help to convey patients’ views to this key public body, while their briefings to Parliamentarians on current legislation like the Health Bill explain to MPs and Peers the views of their members. [17]
2009
MTG ran a number of campaigns throughout 2009, including: publication of MTG Action Plan, research into the wider societal benefits of medical technology, Parliamentary Showcase, and dedicated campaign activity.
Publication of MTG Action Plan: The report “Medical Technology – Can we afford to miss out?” highlighted how the UK lags behind many other European countries in its uptake of proven effective technologies. The report gained broad media coverage, including from the BBC, HSJ and Pharma Times amongst others. The Action Plan has also been endorsed by front bench MPs from both the Conservative and Liberal Democrats.
Research into the wider societal benefits of medical technology: MTG commissioned the York Health Economics Consortium to produce a report which would demonstrate the wider societal benefits of medical technologies, the first phase of this was completed in August.
Parliamentary Showcase: The annual Parliamentary Showcase was held on 13 October at Portcullis House. 18 parliamentarians attended over the course of the event including Norman Lamb MP and Sandra Gidley MP from the Shadow Lib Dem health team, high profile labour MPs, the Deputy Speaker of the House of Commons Sir Alan Haselhurst, and a number of Conservative and cross-bench peers with an interest in health.
Dedicated campaign activity: MTG ran a number of dedicated campaigns, the first of these was around increasing the uptake of Insulin Pumps. MTG had liaised with a number of MPs and expect a series of outputs throughout 2010 [18]
If you would like to view full summary of MTG’s achievements in 2009 follow this link: http://www.abhi.org.uk/multimedia/docs/briefings-in-public/Weber%20Shandwick%20presentation%20FINAL.pdf
2010
Before 2010, MTG's plan was to “utilise the recently launched Action Plan, focusing on Conservatives and wider stakeholders. They also wanted to “build links with think tanks, seek out speaking opportunities and will be looking at holding fringe events at events such as the RCN Congress”. MTG also wanted more press coverage in 2010 than the previous year. They also wanted to focus on “patient need”. [19]
Notes
- ↑ MTG website About MTG, accessed Nov 2010
- ↑ "Nursing Times NHS "must boost use of technology" or risk falling behind 25.11.2009, accessed 09.04.2011
- ↑ Scottish Healthcare Medical Technology Group Warns Against "Slow-Tech" NHS 25.11.2009, accessed 04.042011
- ↑ Department for Business, Innovation & Skills [http://www.bis.gov.uk/assets/biscore/business-sectors/docs/s/10-p90-strength-and-opportunity-bioscience-and-health-technology-sectors.pdf Strength and Opportunity] Dec 2010, accessed 28.03.2011
- ↑ MTG MTG Policy Statements, accessed 11.02.2011
- ↑ AdvaMed What is Medical Technology?, 14.09.2004, accessed 06.04.2011
- ↑ Scottish Healthcare NHS 'must boost use of technology, 25.11.2009, accessed 09.04.2011
- ↑ BMJ Group UK must increase uptake of medical technology to close gap with Europe 03.02.2011, accessed 03.04.2011
- ↑ MTG Members, accessed 11.02.2011
- ↑ MTG and INPUT AUDIT OF INSULIN PUMP THERAPY PROVISION AT PRIMARY CARE TRUST (PCT) LEVEL TO BE PUBLISHED SOON accessed 29.03.2011
- ↑ PR Week Healthcare Tech Group Enlists WS 23.11.2007, accessed 16.04.2011
- ↑ Weber Shandwick. Medical Technology Group, 2009 End of year review and forward look accessed 02.04.2011
- ↑ MTG Joining MTG accessed 11.02.1011
- ↑ MTG Joining MTG accessed 11.02.1011
- ↑ MTG Medical Technology – Can We Afford to Miss Out? 21.12.2009, accessed 20.02.2011
- ↑ MTG Management Committee, accessed 11.02.2011
- ↑ MTG MTG successes, accessed 20.02.2011
- ↑ ABHI Medical Technology Group, accessed 14.02.2011
- ↑ ABHI Medical Technology Group, accessed 14.02.2011
